180 Life Sciences Corp. (NASDAQ: ATNF) Recognized R&D Pioneers in Anti-Inflammatory Therapeutics
NEW YORK, March 26, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – 180 Life Sciences Corp. (NASDAQ: ATNF) announces the availability of a...
Month: March 2021
Cybin Inc. (NEO: CYBN) at Forefront of Psychedelic Revolution
NEW YORK, March 26, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Cybin Inc. (NEO: CYBN) announces the availability of a broadcast titled,...
Assure Holdings Reports Fourth Quarter and Full Year 2020 Financial Results
Full Year 2020 Managed Case Volume Increased 54% to 9,914DENVER, March 26, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the...
Roche receives positive CHMP opinion for Tecentriq as a first-line monotherapy treatment for people with a type of metastatic non-small cell lung cancer
Recommendation is based on the Phase III IMpower110 study showing that Tecentriq significantly improved overall survival in people with high...
The European Medicines Agency’s CHMP issues a positive opinion recommending marketing authorisation for Ponvory (ponesimod) to treat adults with relapsing forms of multiple sclerosis
Allschwil, Switzerland – March 26, 2021 Idorsia Ltd (SIX: IDIA) was informed by the Janssen Pharmaceutical Companies of Johnson &...
Kronos Bio Appoints Taiyin Yang, Ph.D., to Board of Directors
SAN MATEO, Calif. and CAMBRIDGE, Mass., March 26, 2021 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated...
Spectral Announces Fourth Quarter and Fiscal 2020 Results and Corporate Update
TORONTO, March 26, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic...
Avricore Health Announces Return of HealthTab™ Founder to Communications and Marketing Role
The Company welcomes the return of Will Seccombe, co-creator of HealthTab™, as he takes on the Company’s communications strategies to...
Novadiscovery announces new clinical simulation collaboration with Takeda
Novadiscovery announces new clinical simulation collaboration with Takeda Lyon, France – 26 March, 2021 Novadiscovery (“NOVA”), a leading health tech...
Grant of share options and performance shares to members of the Board of Management and key employees
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): Share option programmeAccording to the Company’s remuneration policy which was...
Acerus Announces Amendment to Credit Agreement
TORONTO, March 26, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today announced...
Salvatore Milia Appointed to CLC Board of Directors, Assigned to Lead R&D Efforts for Production of TAAT™
VANCOUVER, British Columbia, March 26, 2021 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake...
MediPharm Labs Expands Wellness Portfolio, Launches Next Generation of Oils with New Unique CBN Rich Formula
MediPharm Labs Expanded family of pharma-quality formulations available in Canada MediPharm Labs Expanded family of pharma-quality formulations available in Canada...
Summit Therapeutics Announces Rights Offering
Cambridge, MA, March 26, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that the Company’s Board of Directors has...
Bavarian Nordic Announces the Resignation of Tommi Kainu as EVP and Chief Business Officer
COPENHAGEN, Denmark, March 26, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that Tommi Kainu, MD, PhD...
Novadiscovery announces new clinical simulation collaboration with Takeda
Novadiscovery announces new clinical simulation collaboration with Takeda Lyon, France – 26 March, 2021 Novadiscovery (“NOVA”), a leading health tech...
UCB SA/NV – Convening notice annual shareholders meeting
*** Unofficial English translation – For convenience purposes only *** UCB SA/NV - Public Limited Liability CompanyAllée de la Recherche...
Design Therapeutics Announces Pricing of Initial Public Offering
CARLSBAD, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc., a biotechnology company developing a platform of gene targeted...
Bright Peak Therapeutics Inc. and Ajinomoto Co., Inc. Enter into a Research Collaboration and License Agreement to Create Novel Immunocytokines
SAN DIEGO and TOKYO, March 25, 2021 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics Inc., a biotechnology company developing next generation...
Alignment Healthcare Announces Pricing of Initial Public Offering
ORANGE, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”), a mission-based, tech-enabled Medicare...